Recent Articles from GlobeNewswire

Paris, France – April 28, 2026

Pratteln, Switzerland, April 28, 2026 – Santhera Pharmaceuticals (SIX: SANN) announces that the Board of Directors of the Italian Medicines Agency, AIFA, has approved the reimbursement of AGAMREE® (vamorolone) for the treatment of patients with Duchenne muscular dystrophy (DMD) aged 4 years and older in Italy.

Ad hoc announcement pursuant to Art. 53 LR

First-quarter 2026 financial information

LOS ANGELES, April 27, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Regencell Bioscience Holdings Limited (“Regencell” or “the Company”) (NASDAQ: RGC) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

NEW YORK, April 27, 2026 (GLOBE NEWSWIRE) --

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Regencell (RGC) To Contact Him Directly To Discuss Their Options

NEW YORK, April 27, 2026 (GLOBE NEWSWIRE) --

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. 

LOS ANGELES, April 27, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against SES AI Corporation (“SES” or “the Company”) (NYSE: SES) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Michael Sztrom and David Sztrom v. Securities and Exchange Commission

CALGARY, Alberta, April 27, 2026 (GLOBE NEWSWIRE) -- In a release issued earlier today by DIRTT Environmental Solutions Ltd. (TSX: DRT; OTCQX: DRTTF), please note that the date has been corrected to May 6, 2026 in the headline. The corrected release follows:

NEW YORK, April 27, 2026 (GLOBE NEWSWIRE) --

NEW YORK, April 27, 2026 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP reminds investors of its investigation on behalf of Veritone, Inc. (“Veritone” or the “Company”) (NASDAQ:VERI) investors concerning the Company’s and/or members of its senior management’s possible violation of the federal securities laws or other unlawful business practices.

NEW YORK, April 27, 2026 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP reminds investors of its investigation on behalf of Nano-X Imaging Ltd. (“Nano-X” or the “Company”) (NASDAQ:NNOX) investors concerning the Company’s and/or members of its senior management’s possible violation of the federal securities laws or other unlawful business practices.

SHANGHAI, China, April 27, 2026 (GLOBE NEWSWIRE) -- Qfin Holdings, Inc. (NASDAQ: QFIN; HKEx: 3660) (“Qfin Holdings” or the “Company”), a leading AI-empowered Credit-Tech platform in China, today published its annual ESG report for 2025. The report demonstrates Qfin Holdings’s ESG-related guidelines, strategies and targets in 2025, highlighting the Company’s efforts to environmental sustainability and social responsibility, the progress to improve corporate governance, and its ESG performance.

MELBOURNE, Australia and INDIANAPOLIS, April 28, 2026 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) announces an educational webinar exploring the evolution of PSMA1-targeted radionuclide therapy and Telix’s differentiated, multi-product approach to treating prostate cancer across the disease continuum.

NEW YORK, April 27, 2026 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP reminds investors of its investigation on behalf of Sportradar Group AG (“Sportradar” or the “Company”) (NASDAQ:SRAD) investors concerning the Company’s and/or members of its senior management’s possible violation of the federal securities laws or other unlawful business practices.

CALGARY, Alberta, April 27, 2026 (GLOBE NEWSWIRE) -- DIRTT Environmental Solutions Ltd. (“DIRTT”, the “Company”, “we”, “our”, “us” or “ours”) (TSX: DRT; OTCQX: DRTTF), a leader in industrialized construction, announced today that it will release its first quarter 2026 financial results on Wednesday, May 6, 2026, after markets close.

SHANGHAI, China, April 27, 2026 (GLOBE NEWSWIRE) -- Qfin Holdings, Inc. (NASDAQ: QFIN; HKEx: 3660) (“Qfin Holdings” or the “Company”), a leading AI-empowered Credit-Tech platform in China, today announced that it has filed its annual report on Form 20-F for the fiscal year ended December 31, 2025 with the U.S. Securities and Exchange Commission on April 27, 2026. The annual report can be accessed on the Company’s investor relations website at https://ir.qfin.com as well as the SEC’s website at www.sec.gov. The Company will provide a hard copy of the annual report containing its audited consolidated financial statements, free of charge, to its shareholders and ADS holders upon request.

LA JOLLA, Calif., April 27, 2026 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875), today announced that a study conducted by researchers at the Spanish National Cancer Research Centre (CNIO) has identified macrophage migration inhibitory factor (MIF)–mediated reprogramming of CD74‑positive microglia and macrophages as a central vulnerability in brain metastasis. The research, recently published in the peer‑reviewed journal “Cancer Research” (March 2026), demonstrates pharmacological modulation of this pathway using the brain‑penetrant small molecule ibudilast.

NEW YORK, April 27, 2026 (GLOBE NEWSWIRE) -- Churchill Capital Corp XII (the “Company”) announced the pricing of its upsized initial public offering of 36,000,000 units at $10.00 per unit. The units will be listed on the Nasdaq Global Market (“Nasdaq”) under the symbol “CXIIU” commencing today. Each unit consists of one Class A ordinary share of the Company and one-tenth of one redeemable warrant, each whole warrant entitling the holder thereof to purchase one Class A ordinary share of the Company at an exercise price of $11.50 per share. Once the securities comprising the units begin separate trading, the Company expects that the Class A ordinary shares and warrants will be listed on Nasdaq under the symbols “CXII” and “CXIIW,” respectively. The offering is expected to close on April 29, 2026, subject to customary closing conditions. 

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Medpace (MEDP) To Contact Him Directly To Discuss Their Options

Company Announces a Record Year of Results for 2025 with Strong Momentum Across Strategic Priorities and Key Financial Metrics Including $1.3M AUV and +50% YoY Store-level Profitability

RANCHO CORDOVA, Calif., April 27, 2026 (GLOBE NEWSWIRE) -- Five Star Bancorp (Nasdaq: FSBC) (“Five Star” or the “Company”), a holding company that operates through its wholly owned banking subsidiary, Five Star Bank (the “Bank”), today reported net income of $18.6 million for the three months ended March 31, 2026, as compared to $17.6 million for the three months ended December 31, 2025 and $13.1 million for the three months ended March 31, 2025.

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Nektar (NKTR) To Contact Him Directly To Discuss Their Options

The privacy-first AI app from Basic Attention Token co-creator Ankur Nandwani opens to the public with one subscription, access to every leading model, and one encrypted memory across them all

VANCOUVER, British Columbia, April 27, 2026 (GLOBE NEWSWIRE) -- Rubicon Organics Inc. (TSXV: ROMJ) (OTCQX: ROMJF) (“Rubicon Organics” or the “Company”), Canada’s leading premium licensed producer focused on cultivating and selling premium and super-premium cannabis products, is pleased to announce that it will be reporting its financial results for the period ended March 31, 2026 (“Q1 2026”) after market close on Wednesday May 13, 2026.   The Company also advises that it has entered into an amendment to temporarily increase its $1.0 million line of credit agreement with Community Savings Credit Union (“CSCU” or the “Lender”) to $2.5 million (the “Amendment”).

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Soleno (SLNO) To Contact Him Directly To Discuss Their Options

SAN CARLOS, Calif., April 27, 2026 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (“Biomea” or “Biomea Fusion” or “the Company”) (Nasdaq: BMEA), a clinical-stage diabetes and obesity company, today announced positive 52-week results from its Phase 2 COVALENT-112 trial evaluating the efficacy, safety, and tolerability of icovamenib in patients with type 1 diabetes (“T1D”). These data are based on a proof-of-concept study enrolling small subsets of Stage 3 T1D patients dosed with icovamenib at 100 mg and 200 mg in two cohorts (patients diagnosed within 3 years and those diagnosed within 3-15 years).

CARY, N.C., April 27, 2026 (GLOBE NEWSWIRE) -- Heron Therapeutics, Inc. (Nasdaq: HRTX) (“Heron” or the “Company”), a commercial-stage biotechnology company, today announced that the Company will host a conference call and live webcast on Monday, May 11, 2026, at 8:30 a.m. ET to report first quarter 2026 financial results and discuss recent business highlights.

In vitro data demonstrated self-complementary AAV9 (scAAV9) enabled ~30-fold higher MeCP2 protein expression compared to single-stranded AAV9 (ssAAV9), supporting the ability to effectively deliver TSHA-102 to the CNS by lumbar IT administration

PALSONIFY is the first once-daily, oral therapy approved to treat acromegaly in the European Union

DAYTONA BEACH, Fla., April 27, 2026 (GLOBE NEWSWIRE) -- Brown & Brown, Inc. (NYSE:BRO) (the "Company") announced its unaudited financial results for the first quarter of 2026.

– Posters detail large gene insertion and epigenetic editing capabilities, expanding ElevateBio’s gene editing toolbox

PHILADELPHIA, April 27, 2026 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc. (Nasdaq: CABA), a late-stage clinical biotechnology company focused on developing and launching targeted cell therapies designed specifically for patients with autoimmune diseases, today announced multiple upcoming presentations including manufacturing, translational and clinical data on rese-cel (resecabtagene autoleucel) at the American Society of Gene & Cell Therapy (ASGCT) 2026 Annual Meeting, being held from May 11-15, 2026, in Boston, MA.

Seven attorneys at Goranson Bain Ausley – one of the largest family law firms in Texas – have been named to D Magazine's 2026 'Best Lawyers in Dallas' list, the most honorees from any single family law firm. The recognition is determined through peer nomination and independent evaluation within the legal community.

ACHESON, Alberta, April 27, 2026 (GLOBE NEWSWIRE) -- North American Construction Group Ltd. (“NACG” or “the Company”) (TSX:NOA.TO/NYSE:NOA) announced today that it will release its financial results for the first quarter ended March 31, 2026 on Wednesday, May 13, 2026 after markets close. Following the release of its financial results, NACG will hold a conference call and webcast on Thursday, May 14, 2026, at 7:00 a.m. Mountain Time (9:00 a.m. Eastern Time).

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In B&W (BW) To Contact Him Directly To Discuss Their Options

- Data underscore the differentiated capability of the clinically validated FORCE platform to cross the blood-brain barrier -

CAMBRIDGE, Mass., April 27, 2026 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a pioneering gene editing company focused on developing transformative medicines for serious diseases, today announced that five abstracts have been accepted for presentation, including one oral presentation and two poster presentations at the American Society of Gene and Cell Therapy (ASGCT) 2026 Annual Meeting, one oral presentation at TIDES USA 2026: Oligonucleotide and Peptide Therapeutics Conference, and one oral presentation at the 94th European Atherosclerosis Society (EAS) Congress. The Company is presenting new preclinical data, including data to support the potential of EDIT-401, its lead in vivo development candidate, to be a transformative therapy for people living with hyperlipidemia.

SEATTLE, April 27, 2026 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that an abstract highlighting preclinical data from SG293, its CD19-directed in vivo CAR T product candidate, has been accepted for oral presentation at the American Society of Gene & Cell Therapy (ASGCT) 2026 Annual Meeting taking place May 11-15, 2026 in Boston, MA.

WALTHAM, Mass., April 27, 2026 (GLOBE NEWSWIRE) -- TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biotechnology company focused on the development of T cell receptor (TCR)-engineered T cell (TCR-T) therapies for the treatment of patients with cancer, today announced the acceptance of an abstract for poster presentation at the upcoming American Society of Gene and Cell Therapy (ASGCT) 29ᵗʰ Annual Meeting being held May 11 – 15 in Boston, MA as well as virtually.

LIMASSOL, Cyprus, April 27, 2026 (GLOBE NEWSWIRE) -- Robin Energy Ltd. (NASDAQ: RBNE) (“Robin Energy” or the “Company”), an international ship-owning company providing energy transportation services globally, announces today the final results of its tender offer (the “Offer”), which expired at 5:00 P.M. Eastern time on April 23, 2026.

Wilmington, DE, April 27, 2026 (GLOBE NEWSWIRE) -- Charlton Aria Acquisition Corporation (Nasdaq: CHARU), a Cayman Islands exempted company (the “Company”) today announced that on April 24, 2026, ST Sponsor II Limited (the “Sponsor”) of the Company deposited $850,000 into the trust account, as a result of which, the Company has until July 25, 2026 to complete its initial business combination (the “Extension”).

NEW YORK, April 27, 2026 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene editing platform to develop life-saving cell and gene therapies, today presents new research on a TALE-based epigenetic editing approach, that does not cut or permanently modify the DNA sequence, making it a potentially safer alternative for genome editing, at the American Society of Gene and Cell Therapy (ASGCT) annual meeting, that will be held on May 11-15, in Boston (MA).

NEW YORK, April 27, 2026 (GLOBE NEWSWIRE) -- Marex Group plc (NASDAQ: MRX) today announced that it will release its fiscal 2026 first quarter results before market open on Wednesday, May 6, 2026. The earnings release and supplementary materials will be available through the "Investors" section of the Marex website at https://ir.marex.com/.

PITTSBURGH, April 27, 2026 (GLOBE NEWSWIRE) -- Montauk Renewables, Inc. ("Montauk” or “the Company") (NASDAQ: MNTK), a renewable energy company specializing in the management, recovery and conversion of biogas into renewable natural gas (“RNG”), will host a conference call and webcast on Thursday, May 7, 2026, at 8:30 a.m. Eastern time to discuss its financial results for the first quarter ended March 31, 2026. The Company will issue a press release reporting the financial results after the close of regular stock market trading hours on the day prior to the conference call and webcast.     

HAMBURG, Germany and AUSTIN, Texas, April 27, 2026 (GLOBE NEWSWIRE) -- XCHG Limited (“XCharge” or the “Company”) (Nasdaq: XCH), an integrated EV charging and energy solutions company, today announced that it filed its annual report on Form 20-F for the fiscal year ended December 31, 2025 with the U.S. Securities and Exchange Commission (the “SEC”) on April 27, 2026. The annual report can be accessed on the SEC’s website at https://www.sec.gov and on the Company’s investor relations website at https://investors.xcharge.com/.

IRVINE, Calif., April 27, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced that management will present at the Bank of America Securities Health Care Conference in Las Vegas on Tuesday, May 12, 2026 at 2:20 pm Eastern Time (11:20 am Pacific Time).

NEW YORK, April 27, 2026 (GLOBE NEWSWIRE) -- Prospect Enhanced Yield Fund (“PENF” or the “Fund”) announced today that the Fund’s Board of Directors has declared monthly cash shareholder distributions for April 2026, May 2026, and June 2026. These distributions represent the seventh, eighth, and nineth monthly distributions paid by the Fund.

SEATTLE, April 27, 2026 (GLOBE NEWSWIRE) -- Trupanion, Inc. (Nasdaq: TRUP), a leader in medical insurance for cats and dogs, has published its 2025 annual shareholder letter from CEO and President, Margi Tooth. The letter is now available on the Company’s Investor Relations website here.

The Shelf Prospectus is accessible, and the Supplement will be accessible within two business days, under the Company's issuer profile on SEDAR+.

MENLO PARK, Calif., April 27, 2026 (GLOBE NEWSWIRE) -- Oruka Therapeutics, Inc. (Nasdaq: ORKA), a clinical-stage biopharmaceutical company focused on developing novel monoclonal antibody therapeutics for psoriasis and other inflammatory and immunology indications, today announced that it has commenced an underwritten public offering of $500 million of shares of its common stock and, in lieu of common stock to certain investors, pre-funded warrants to purchase shares of its common stock. In addition, Oruka expects to grant the underwriters a 30-day option to purchase up to an additional $75 million of shares of its common stock at the public offering price, less underwriting discounts and commissions. The proposed public offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed or as to the actual size or terms of the offering. All of the shares of common stock and pre-funded warrants are being offered by Oruka.

FREMONT, Calif., April 27, 2026 (GLOBE NEWSWIRE) -- Enovix Corporation (Nasdaq: ENVX) (“Company” or “Enovix”), a developer and manufacturer of advanced lithium-ion batteries, including proprietary silicon-anode architectures, today announced it will report financial results for the first quarter on Wednesday, May 13, 2026, after the close of the market.

Q1 2026 adjusted EPS* above the high end of our guidance range;Raising 2026 annual outlook

NEW YORK, April 27, 2026 (GLOBE NEWSWIRE) -- Apollo Commercial Real Estate Finance, Inc. (the “Company” or “ARI”) (NYSE:ARI) today announced the Board of Directors set May 18, 2026 as the record date for the Company's 2026 Annual Meeting of Stockholders. The Annual Meeting of Stockholders will be held virtually on July 9, 2026 at 10:00 am Eastern Time. Information on the virtual meeting will be included in the ARI 2026 proxy statement.

Net Loss per Diluted Share of $0.07 for the Quarter

Grants of up to $200,000 available to community organizations across Arizona, California and Nevada in partnership with member financial institutions

ROCKVILLE, Md., April 27, 2026 (GLOBE NEWSWIRE) -- Capital Bancorp, Inc. (the "Company") (NASDAQ: CBNK), the holding company for Capital Bank, N.A. (the "Bank"), today reported:

New release pairs targeted audience growth with developed partnership ecosystem

SAN JOSE, Calif., April 27, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to improve clinical outcomes in dialysis with less cost and complexity, today announced that it will release financial results for the first quarter 2026 after the close of trading on Thursday, May 7, 2026.

LOS ANGELES, April 27, 2026 (GLOBE NEWSWIRE) -- WEBTOON Entertainment Inc. (Nasdaq: WBTN) (“WEBTOON Entertainment,” or “the Company”), a leading global entertainment company and home to some of the world’s largest storytelling platforms, today announced that it plans to report first quarter 2026 financial results after market close on May 11, 2026. Following the release, the Company’s management team will host a conference call at 4:30 p.m. ET to review the results.

RICHARDSON, Texas, April 27, 2026 (GLOBE NEWSWIRE) -- Fossil Group, Inc. (NASDAQ: FOSL) announced today that it will report first quarter 2026 financial results after market close on Wednesday, May 13, 2026, followed by a conference call to discuss the results at 5:00 p.m. ET the same day. The call can be accessed live on the Company’s investor relations website at www.fossilgroup.com/investors and will also be archived for replay.

FORT MYERS, Fla., April 27, 2026 (GLOBE NEWSWIRE) -- Alico, Inc. (“Alico” or the “Company”) (Nasdaq: ALCO) today announced that the Company will release financial results for the second quarter ended March 31, 2026, on Monday, May 11, 2026 after market close.

BERKELEY, Calif., April 27, 2026 (GLOBE NEWSWIRE) -- Rigetti Computing, Inc. ("Rigetti" or the "Company") (Nasdaq: RGTI), a pioneer in hybrid quantum-classical computing, announced today that it will release first quarter 2026 results on Monday, May 11, 2026, after market close. The Company will host a conference call to discuss its financial results and provide an update on its business operations at 5:00 pm ET the same day.

Lima, April 27, 2026 (GLOBE NEWSWIRE) -- Lima, Peru, April 27, 2026 - Credicorp Ltd. (“Credicorp”) (NYSE: BAP | BVL: BAP) has filed its Annual Report on Form 20-F for the year ended December 31, 2025, with the Securities and Exchange Commission. The 2025 Form 20-F includes audited consolidated financial statements of Credicorp and its subsidiaries as of December 31, 2024 and 2025 and for the years ended December 31, 2023, 2024 and 2025 under International Financial Reporting Standards (IFRS).

LOS ANGELES, April 27, 2026 (GLOBE NEWSWIRE) -- Crescent Capital BDC, Inc. (“Crescent BDC”) (NASDAQ: CCAP) today announced it will release its financial results for the first quarter ended March 31, 2026 on Wednesday, May 13, 2026 after market close. Crescent BDC invites all interested persons to attend its webcast/conference call on Thursday, May 14, 2026 at 12:00 p.m. Eastern Time to discuss its first quarter ended March 31, 2026 financial results.

SAN FRANCISCO, April 27, 2026 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic diseases, with a focus on obesity, today announced multiple presentations at the American Diabetes Association (ADA) 86th Scientific Sessions, taking place June 5–8, 2026 in New Orleans, Louisiana. The presentations include an oral presentation on the ACCESS Phase 2b clinical trial of aleniglipron.

MALMÖ, Sweden, April 27, 2026 (GLOBE NEWSWIRE) -- Oatly Group AB (publ) (Nasdaq: OTLY), the world’s original and largest oat drink company, has today published its Swedish annual report for the twelve months ended December 31, 2025 (the “Swedish Annual Report”).

Southfield, Michigan, April 27, 2026 (GLOBE NEWSWIRE) -- Credit Acceptance Corporation (Nasdaq: CACC) (referred to as the “Company”, “Credit Acceptance”, “we”, “our”, or “us”) announced today that Robert Bourrier has joined the Company as Chief Sales Officer.

WAUWATOSA, Wis., April 27, 2026 (GLOBE NEWSWIRE) -- Waterstone Financial, Inc. (NASDAQ: WSBF) (the “Company”) announced that on April 27, 2026, its Board of Directors authorized the repurchase of up to an additional 2,000,000 shares of the Company’s outstanding shares of common stock under its existing repurchase program. Prior to this authorization, 148,285 shares remained available to repurchase under the existing program. Combined with the shares authorized today, the total 2,148,285 shares available for repurchase represent approximately 11.9% of the Company’s issued and outstanding shares of common stock as of April 27, 2026. The timing of the repurchases will depend on certain factors, including but not limited to market conditions and prices, available funds and alternative uses of capital. The stock repurchase program may be carried out through open-market repurchases, block trades, negotiated private transactions and pursuant to a trading plan that will be adopted in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934. Any repurchased shares will be treated as authorized but unissued by the Company. The repurchase program may be suspended, terminated or modified at any time for any reason, including market conditions, the cost of repurchasing shares, the availability of alternative investment opportunities, liquidity, and other factors deemed appropriate. The repurchase program does not obligate the Company to repurchase any particular number of shares.

NEW YORK, April 27, 2026 (GLOBE NEWSWIRE) -- VisionSys AI Inc. (NASDAQ: VSA) (“VSA” or the “Company”) today announced that it is in advanced discussions with a strategic investor regarding a proposed strategic investment. Based on the terms currently under discussion, the investor plans to invest a total of $90 million in VSA at a price of $1.50 per share.

NEW YORK, April 27, 2026 (GLOBE NEWSWIRE) --

NEW YORK, April 27, 2026 (GLOBE NEWSWIRE) -- EXL [NASDAQ: EXLS], a global data and AI company, announced, it has been named the 2025 New Partner of the Year by Genesys®, a global cloud leader in AI-Powered Experience Orchestration. The Genesys Partner of the Year Awards celebrate partners that orchestrate exceptional experiences and collaborate with Genesys to advance transformative solutions with real-world impact.